Skip to main content

Advertisement

Log in

Should the use of neck-ultrasonography be reduced during the follow-up of differentiated thyroid cancer patients with undetectable or low (i.e., < 1 µg/L) thyroglobulin levels and negative thyroglobulin antibody?

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Pacini F, Basolo F, Bellantone R et al (2018) Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Investig 41(7):849–876. https://doi.org/10.1007/s40618-018-0884-2

    Article  CAS  Google Scholar 

  2. Yang SP, Bach AM, Tuttle RM, Fish SA (2015) Serial neck ultrasound is more likely to identify false positive abnormalities than clinically significant disease in low risk papillary thyroid cancer patients. Endocr Pract 21:1372–1379

    Article  Google Scholar 

  3. Verburg FA, Mäder U, Giovanella L, Luster M, Reiners C (2018) Low or undetectable basal thyroglobulin levels obviate the need for neck ultrasound in differentiated thyroid cancer patients after total thyroidectomy and 131I ablation. Thyroid 28(6):722–728. https://doi.org/10.1089/thy.2017.0352

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Campennì.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

A written informed consent was obtained from each patient.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Campennì, A., Tulchinsky, M. Should the use of neck-ultrasonography be reduced during the follow-up of differentiated thyroid cancer patients with undetectable or low (i.e., < 1 µg/L) thyroglobulin levels and negative thyroglobulin antibody?. J Endocrinol Invest 42, 105–106 (2019). https://doi.org/10.1007/s40618-018-0957-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-018-0957-2

Keywords

Navigation